Global Custom Market Research Reports Provider Company

phone

TESARO Inc (TSRO) - Financial and Strategic SWOT Analysis Review

  • Published Date: 27 Jun 2018
  • Number of Pages: 60
  • Category: SWOT Analysis
  • Country: United States of America
TESARO Inc (TSRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The companys product portfolio includes ZEJULA (niraparib), to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer and VARUBI (rolapitant) for the prevention of chemotherapy induced nausea and vomiting (CINV). TESARO sells its products directly to hospitals and clinics, and to a limited number of specialty distributors and pharmacy providers in the US and to certain wholesale distributors in Europe. TESARO is headquartered in Waltham, Massachusetts, the US.

TESARO Inc Key Recent Developments

May 08,2018: Psychological Effects of Ovarian Cancer Often Overlooked But Can Have a Significant Impact on Patients
May 03,2018: TESARO Announces First-Quarter 2018 Operating Results
Apr 19,2018: TESARO to Receive 2018 Partnership Award at CancerCare Gala
Feb 27,2018: TESARO Announces Fourth-Quarter and Full-Year 2017Operating Results
Nov 07,2017: TESARO Announces Third-Quarter 2017 Operating Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
TESARO Inc - Key Facts 6
TESARO Inc - Key Employees 7
TESARO Inc - Key Employee Biographies 8
TESARO Inc - Major Products and Services 10
TESARO Inc - History 12
TESARO Inc - Company Statement 15
TESARO Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 Company Analysis 18
Company Overview 18
TESARO Inc - Business Description 19
TESARO Inc - Corporate Strategy 20
TESARO Inc - SWOT Analysis 21
SWOT Analysis - Overview 21
TESARO Inc - Strengths 21
TESARO Inc - Weaknesses 22
TESARO Inc - Opportunities 23
TESARO Inc - Threats 24
TESARO Inc - Key Competitors 25
Section 3 Company Financial Ratios 26
Financial Ratios - Capital Market Ratios 26
Financial Ratios - Annual Ratios 27
Performance Chart 29
Financial Performance 29
Financial Ratios - Interim Ratios 30
Financial Ratios - Ratio Charts 31
Section 4 Companys Lifesciences Financial Deals and Alliances 32
TESARO Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32
TESARO Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33
TESARO Inc, Recent Deals Summary 34
Section 5 Companys Recent Developments 35
May 08, 2018: Psychological Effects of Ovarian Cancer Often Overlooked But Can Have a Significant Impact on Patients 35
May 03, 2018: TESARO Announces First-Quarter 2018 Operating Results 37
Apr 19, 2018: TESARO to Receive 2018 Partnership Award at CancerCare Gala 38
Feb 27, 2018: TESARO Announces Fourth-Quarter and Full-Year 2017Operating Results 39
Nov 07, 2017: TESARO Announces Third-Quarter 2017 Operating Results 43
Sep 28, 2017: TESARO Expands Our Way Forward Program for the Ovarian Cancer Community and Partners With Olympic Gymnast Shannon Miller 45
Aug 08, 2017: TESARO Announces Second-Quarter 2017 Operating Results 47
Jun 03, 2017: TESARO Provides Business and Pipeline Update at ASCO Investor Briefing 49
May 09, 2017: TESARO Announces First-Quarter 2017 Operating Results 52
Feb 28, 2017: TESARO Announces Fourth-Quarter 2016 Operating Results 54
Section 6 Appendix 56
Methodology 56
Ratio Definitions 56
About GlobalData 60
Contact Us 60
Disclaimer 60

List Of Tables

List of Tables
TESARO Inc, Key Facts 6
TESARO Inc, Key Employees 7
TESARO Inc, Key Employee Biographies 8
TESARO Inc, Major Products and Services 10
TESARO Inc, History 12
TESARO Inc, Subsidiaries 17
TESARO Inc, Key Competitors 25
TESARO Inc, Ratios based on current share price 26
TESARO Inc, Annual Ratios 27
TESARO Inc, Annual Ratios (Cont...1) 28
TESARO Inc, Interim Ratios 30
TESARO Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32
TESARO Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33
TESARO Inc, Recent Deals Summary 34
Currency Codes 56
Capital Market Ratios 56
Equity Ratios 57
Profitability Ratios 57
Cost Ratios 58
Liquidity Ratios 58
Leverage Ratios 59
Efficiency Ratios 59

List Of Figures

List of Figures
TESARO Inc, Performance Chart (2013 - 2017) 29
TESARO Inc, Ratio Charts 31
TESARO Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32
TESARO Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33

TESARO Inc (TSRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules

View Report

TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports